News
11-20-2008, 09:10 PM
Bionovo, Inc. (NASDAQ:BNVI) announced the company will present results from the Phase 1B clinical trial of their lead drug candidate for advanced metastatic breast cancer, BZL101, at the Society for Integrative Oncology's Fifth International Conference in Atlanta, Georgia.
More... (http://www.news-medical.net/?id=43234)
More... (http://www.news-medical.net/?id=43234)